Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Read more about Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.
HER Targeting in HER2-Negative Breast Cancers: Looking for the HER3 Positive. Read more about HER Targeting in HER2-Negative Breast Cancers: Looking for the HER3 Positive.
A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection. Read more about A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma. Read more about Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
Circulating tumor cell analysis in metastatic triple-negative breast cancers. Read more about Circulating tumor cell analysis in metastatic triple-negative breast cancers.
Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Read more about Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Read more about Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Read more about Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
HER2 as a therapeutic target in head and neck squamous cell carcinoma. Read more about HER2 as a therapeutic target in head and neck squamous cell carcinoma.
